HomeAuthorsPosts by admin

admin

1868 POSTS6 COMMENTS

Latest Pharma-News

Bayer Pharmaceuticals accelerates innovations for patients

admin - March 27, 2023 0

Latest Pharma-News

Macomics and Ono Pharmaceutical partner to discover Cancer therapy

admin - March 27, 2023 0

Latest Pharma-News

Debiopharm announces launch of galuci study for its Caix-Targeted radiopharmaceutical program

admin - March 27, 2023 0

Latest Pharma-News

AZ’s Eplontersen shpows benefit for hereditary transthyretin-mediated amyloid polyneuropathy through 66 weeks

admin - March 27, 2023 0

Latest Pharma-News

Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis for breast cancer

admin - March 27, 2023 0

Latest Pharma-News

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval

admin - March 27, 2023 0

Latest Pharma-News

Sandoz receives US FDA approval for biosimilar Hyrimoz® high-concentration formulation

admin - March 24, 2023 0

Latest Pharma-News

Calquence granted first regulatory approval in China for adults with previously treated mantle cell lymphoma

admin - March 24, 2023 0

Latest Pharma-News

Bayer’s Nubeqa™ approved for additional prostate cancer indication in China

admin - March 21, 2023 0

Latest Pharma-News

FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products

admin - March 21, 2023 0

Latest Pharma-News

Pfizer’s XTANDI® plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer

admin - March 20, 2023 0

Latest Pharma-News

FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products

admin - March 20, 2023 0

1...456...156 Page 5 of 156

TOP AUTHORS

admin

1868 POSTS6 COMMENTS

OIdMIHuOdiu

0 POSTS0 COMMENTS

tintin

0 POSTS0 COMMENTS

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

February 10, 2025

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

February 3, 2025

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

February 3, 2025

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

January 24, 2025

admin

TOP AUTHORS

Most Read

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

CRASH COURSE ON CLINICAL DATA MANAGEMENT

Interview Questions on Institutional Review Board(IRB)

POPULAR POSTS

How to Find Paid Clinical Trials Near You

What Is CDISC and What Are CDISC Data Standards?

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

POPULAR CATEGORY

ABOUT US

FOLLOW US